190 related articles for article (PubMed ID: 33551434)
21. Effect of liver dysfunction on outcome of radioactive iodine therapy for Graves' disease.
Ze Y; Shao F; Feng X; Shen S; Bi Y; Zhu D; Zhang X
BMC Endocr Disord; 2022 Dec; 22(1):319. PubMed ID: 36522617
[TBL] [Abstract][Full Text] [Related]
22. Prevention of Orbitopathy by Oral or Intravenous Steroid Prophylaxis in Short Duration Graves' Disease Patients Undergoing Radioiodine Ablation: A Prospective Randomized Control Trial Study.
Vannucchi G; Covelli D; Campi I; Currò N; Dazzi D; Rodari M; Pepe G; Chiti A; Guastella C; Lazzaroni E; Salvi M
Thyroid; 2019 Dec; 29(12):1828-1833. PubMed ID: 31860407
[No Abstract] [Full Text] [Related]
23. Radioiodine-Induced Salivary Gland Damage Detected by Ultrasonography in Patients Treated for Papillary Thyroid Cancer: Radioactive Iodine Activity and Risk.
Horvath E; Skoknic V; Majlis S; Tala H; Silva C; Castillo E; Whittle C; Niedmann JP; González P
Thyroid; 2020 Nov; 30(11):1646-1655. PubMed ID: 32370663
[No Abstract] [Full Text] [Related]
24. Radioactive iodine therapy for pediatric Graves' disease: a single-center experience over a 10-year period.
Kaplowitz PB; Jiang J; Vaidyanathan P
J Pediatr Endocrinol Metab; 2020 Mar; 33(3):383-389. PubMed ID: 31603857
[TBL] [Abstract][Full Text] [Related]
25. Radioiodine treatment of hyperthyroidism: prognostic factors affecting outcome.
Erem C; Kandemir N; Hacihasanoglu A; Ersöz HO; Ukinc K; Kocak M
Endocrine; 2004 Oct; 25(1):55-60. PubMed ID: 15545707
[TBL] [Abstract][Full Text] [Related]
26. Factors affecting timing of hypothyroidism following radioactive iodine therapy (RAIT) for patients with Graves' disease: A 12-month observational study.
Mahmoud HA; Alsanory AAAA; Mostafa HG; Hassan ER
Nucl Med Commun; 2024 Jun; 45(6):499-509. PubMed ID: 38586956
[TBL] [Abstract][Full Text] [Related]
27. Cardiovascular Outcomes of Thyroidectomy or Radioactive Iodine Ablation for Graves' Disease.
Gibson A; Dave A; Johnson C; Kotwal A; Fingeret AL
J Surg Res; 2020 Dec; 256():486-491. PubMed ID: 32798996
[TBL] [Abstract][Full Text] [Related]
28. Immune reconstitution inflammatory syndrome-associated Graves disease in HIV-infected patients: clinical characteristics and response to radioactive iodine therapy.
Lawal IO; Orunmuyi AT; Popoola GO; Mokoala KMG; Lengana T; Sathekge MM
HIV Med; 2021 Nov; 22(10):907-916. PubMed ID: 34328251
[TBL] [Abstract][Full Text] [Related]
29. Hyperparathyroidism subsequent to radioactive iodine therapy for Graves' disease.
Law RH; Quan DL; Stefan AJ; Peterson EL; Singer MC
Head Neck; 2021 Oct; 43(10):2994-3000. PubMed ID: 34124812
[TBL] [Abstract][Full Text] [Related]
30. Selective Use of Radioactive Iodine Therapy for Papillary Thyroid Cancers With Low or Lower-Intermediate Recurrence Risk.
Grani G; Lamartina L; Alfò M; Ramundo V; Falcone R; Giacomelli L; Biffoni M; Filetti S; Durante C
J Clin Endocrinol Metab; 2021 Mar; 106(4):e1717-e1727. PubMed ID: 33377969
[TBL] [Abstract][Full Text] [Related]
31. High-Dose RAI Therapy Justified by Pathological N1a Disease Revealed by Prophylactic Central Neck Dissection for cN0 Papillary Thyroid Cancer Patients: Is it Superior to Low-Dose RAI Therapy?
Wei L; Bai L; Zhao L; Yu T; Ma Q; Ji B
World J Surg; 2019 May; 43(5):1256-1263. PubMed ID: 30684002
[TBL] [Abstract][Full Text] [Related]
32. Long-term outcomes and prognostic factors in papillary thyroid microcarcinoma patients with distant metastases.
Weng HY; Yan T; Qiu WW; Xi C; Hou LY; Yang ZL; Qiu ZL
Endocrine; 2022 Feb; 75(2):495-507. PubMed ID: 34699028
[TBL] [Abstract][Full Text] [Related]
33. Age moderates the associations between TRAbs, free T3 and outcomes of Graves' disease patients with radioactive iodine treatment.
Lu L; Gao C; Zhang N
Clin Endocrinol (Oxf); 2021 Feb; 94(2):303-309. PubMed ID: 32734611
[TBL] [Abstract][Full Text] [Related]
34. Predictive factors for early hypothyroidism following the radioactive iodine therapy in Graves' disease patients.
Hu RT; Liu DS; Li B
BMC Endocr Disord; 2020 May; 20(1):76. PubMed ID: 32471411
[TBL] [Abstract][Full Text] [Related]
35. Clinical outcome of patients with papillary thyroid carcinoma who have recurrence after initial radioactive iodine therapy.
Vassilopoulou-Sellin R; Schultz PN; Haynie TP
Cancer; 1996 Aug; 78(3):493-501. PubMed ID: 8697396
[TBL] [Abstract][Full Text] [Related]
36. Quality of Life in Patients with Papillary Thyroid Microcarcinoma According to Treatment: Total Thyroidectomy with or without Radioactive Iodine Ablation.
Ahn J; Jeon MJ; Song E; Kim TY; Kim WB; Shong YK; Kim WG
Endocrinol Metab (Seoul); 2020 Mar; 35(1):115-121. PubMed ID: 32207271
[TBL] [Abstract][Full Text] [Related]
37. Impaired Quality of Life After Radioiodine Therapy Compared to Antithyroid Drugs or Surgical Treatment for Graves' Hyperthyroidism: A Long-Term Follow-Up with the Thyroid-Related Patient-Reported Outcome Questionnaire and 36-Item Short Form Health Status Survey.
Törring O; Watt T; Sjölin G; Byström K; Abraham-Nordling M; Calissendorff J; Cramon PK; Filipsson Nyström H; Hallengren B; Holmberg M; Khamisi S; Lantz M; Wallin G
Thyroid; 2019 Mar; 29(3):322-331. PubMed ID: 30667296
[TBL] [Abstract][Full Text] [Related]
38. Impaired immune regulation after radioiodine therapy for Graves' disease and the protective effect of Methimazole.
Côté-Bigras S; Tran V; Turcotte S; Rola-Pleszczynski M; Verreault J; Rottembourg D
Endocrine; 2016 Jun; 52(3):587-96. PubMed ID: 26701678
[TBL] [Abstract][Full Text] [Related]
39. Fine needle aspiration biopsy of the thyroid gland in patients with prior Graves' disease treated with radioactive iodine. Morphologic findings and potential pitfalls.
Centeno BA; Szyfelbein WM; Daniels GH; Vickery AL
Acta Cytol; 1996; 40(6):1189-97. PubMed ID: 8960027
[TBL] [Abstract][Full Text] [Related]
40. High Thyroid Stimulating Receptor Antibody Titre and Large Goitre Size at First-Time Radioactive Iodine Treatment are Associated with Treatment Failure in Graves' Disease.
Tay WL; Chng CL; Tien CS; Loke KS; Lam WW; Fook-Chong SM; Tong AK
Ann Acad Med Singap; 2019 Jun; 48(6):181-187. PubMed ID: 31377762
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
